Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.45 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.45 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.45 |
| ▸ | BLM | P54132 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | GRIK5 | Q16478 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | TYMP | P19971 | 8/20 | 0.40 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.40 |
| ▸ | TK1 | P04183 | 4/20 | 0.37 |
| ▸ | DPYD | Q12882 | 1/20 | 0.37 |
| ▸ | PYGM | P11217 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19841638 | 0.74 | KMT2A (0.42) | TDP1CYP1A2GRIA1GRIA2GRIA4 | |
| SCHEMBL646139 | 0.74 | TDP1 (0.59) | TDP1BLMTYMPCRBNTK1 | |
| SCHEMBL400005 | 0.73 | TDP1 (1.00) | TDP1CYP1A2GRIA1GRIA2GRIA4 | |
| SCHEMBL4379055 | 0.73 | DAO (0.43) | CYP1A2GRIA1GRIA2GRIA4BLM | |
| SCHEMBL10939258 | 0.73 | DPYD (0.41) | TDP1CYP1A2GRIA1GRIA2GRIA4 | |
| SCHEMBL9192075 | 0.73 | TDP1 (0.57) | TDP1CYP1A2GRIA1GRIA2GRIA4 | |
| SCHEMBL9192590 | 0.73 | TDP1 (0.57) | TDP1CYP1A2GRIA1GRIA2GRIA4 | |
| SCHEMBL17041835 | 0.70 | TDP1 (0.53) | TDP1CYP1A2KMT2ACRBNTK1 | |
| SCHEMBL933036 | 0.68 | TK1 (0.43) | TDP1CYP1A2GRIA1GRIA2GRIA4 | |
| SCHEMBL12747301 | 0.68 | CYP1A2 (0.41) | CYP1A2GRIA1GRIA2GRIA4BLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2015125782-A1 | METHOD FOR PRODUCING THIOLANE-SKELETON GLYCOCONJUGATE, AND THIOLANE-SKELETON GLYCOCONJUGATE | 富士フイルム株式会社 | 2015-08-27 | — | — | WO | disclosed |
| WO-2015125781-A1 | METHOD FOR PRODUCTING THIOLANE SKELETON-TYPE GLYCOCONJUGATE, AND THIOLANE SKELETON-TYPE GLYCOCONJUGATE | 富士フイルム株式会社 | 2015-08-27 | — | — | WO | disclosed |
| EP-0425669-B1 | 1-AMINO-5-HALOGENOURACILS, PROCESS FOR THEIR PREPARATION, AND CENTRAL NERVOUS SYSTEM DEPRESSANTS CONTAINING SAME AS ACTIVE INGREDIENT | YAMASA SHOYU KK (JP) | 1995-01-25 | — | — | EP | disclosed |
| US-5334593-A | Anxiolytic drugs | YAMASA SHOYU KABUSHIKI KAISHA (JP) | 1994-08-02 | — | — | US | disclosed |
| US-5252576-A | 1-amino-5-halogenouracils, process for their preparation, and central nervous system depressants containing same as active ingredient | YAMASA SHOYU KABUSHIKI KAISHA (JP) | 1993-10-12 | — | — | US | disclosed |
| EP-0509098-A1 | ATARACTIC | Yamasa Shoyu Kabushiki Kaisha (JP) | 1992-10-21 | — | — | EP | disclosed |
| EP-0425669-A1 | 1-AMINO-5-HALOGENOURACILS, PROCESS FOR THEIR PREPARATION, AND CENTRAL NERVOUS SYSTEM DEPRESSANTS CONTAINING SAME AS ACTIVE INGREDIENT | Yamasa Shoyu Kabushiki Kaisha also trading as Yamasa Corporation (JP) | 1991-05-08 | — | — | EP | disclosed |